Inducible over-expression of wild type α-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death

Journal of Neurochemistry

Volumn 109, Issue 5, 2009, Pages 1348-1362

  Vekrellis, Kostas ^a   Xilouri, Maria ^a   Emmanouilidou, Evangelia ^a   Stefanis, Leonidas ^a,b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

synuclein; Apoptosis; Mitochondria; Oligomers; Parkinson's disease; Toxicity

Indexed keywords

ALPHA SYNUCLEIN; CASPASE 3; CASPASE 9; CYTOCHROME C;

APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; NEUROTOXICITY; OLIGOMERIZATION; PRIORITY JOURNAL;

ALPHA-SYNUCLEIN; AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; BCL-X PROTEIN; CASPASES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; INOSITOL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEUROBLASTOMA; STAUROSPORINE; TIME FACTORS; TRANSFECTION; TRETINOIN;

EID: 65549102934     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06054.x     Document Type: Article

References (50)

1. Adams J. M. Cory S. (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26, 61 66.
2. Adams J. M. Cory S. (2002) Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol. 14, 715 720. (Pubitemid 35449383)
3. Bao Q. Shi Y. (2007) Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 14, 56 65.
4. Behbahani H., Rickle A., Concha H., Ankarcrona M., Winblad B. Cowburn R. F. (2005) Flow cytometry as a method for studying effects of stressors on primary rat neurons. J. Neurosci. Res. 82, 432 441. (Pubitemid 41552494)
5. Behbahani H., Shabalina I. G., Wiehager B., Concha H., Hultenby K., Petrovic N., Nedergaard J., Winblad B., Cowburn R. F. Ankarcrona M. (2006) Differential role of Presenilin-1 and -2 on mitochondrial membrane potential and oxygen consumption in mouse embryonic fibroblasts. J. Neurosci. Res. 84, 891 902. (Pubitemid 44366690)
6. Bredesen D. E. (2008) Programmed cell death mechanisms in neurological disease. Curr. Mol. Med. 8, 173 186.
7. Chartier-Harlin M. C., Kachergus J., Roumier C. et al. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167 1169. (Pubitemid 39296604)
8. Chu Y. Kordower J. H. (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease? Neurobiol. Dis. 25, 134 149.
9. Chu Y., Le W., Kompoliti K., Jankovic J., Mufson E. J. Kordower J. H. (2006) Nurr1 in Parkinson's disease and related disorders. J. Comp. Neurol. 494, 495 514. (Pubitemid 41790998)
10. Constantinescu R., Constantinescu A. T., Reichmann H. Janetzky B. (2007) Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. J. Neural Transm. Suppl. 72, 17 28.
11. Cooper A. A., Gitler A. D., Cashikar A. et al. (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 21, 324 328. (Pubitemid 44480951)
12. Cossarizza A., Ceccarelli D. Masini A. (1996) Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level. Exp. Cell Res. 222, 84 94. (Pubitemid 26046576)
13. Dauer W. Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889 909. (Pubitemid 37130207)
14. Degterev A., Boyce M. Yuan J. (2003) A decade of caspases. Oncogene 22, 8543 8567. (Pubitemid 38028527)
15. Deshusses J. Reber G. (1977) Assymetry of the myo-inositol transport system in Klebsiella aerogenes. Energy is necessary to create the assymetry of the transport system. Eur. J. Biochem. 72, 101 106. (Pubitemid 8010792)
16. Emmanouilidou E., Stefanis L. Vekrellis K. (2008) Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol. Aging. [Epub ahead of print] doi :.
17. Farinelli S. E., Greene L. A. Friedman W. J. (1998) Neuroprotective actions of dipyridamole on cultured CNS neurons. J. Neurosci. 18, 5112 5123. (Pubitemid 28311929)
18. Ibanez P., Bonnet A. M., Debarges B., Lohmann E., Tison F., Pollak P., Agid Y., Durr A. Brice A. (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169 1171. (Pubitemid 39296605)
19. Kaiser L. G., Schuff N., Cashdollar N. Weiner M. W. (2005) Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla. NMR Biomed. 18, 51 55. (Pubitemid 40347543)
20. Kim C. Lee S. J. (2008) Controlling the mass action of alpha-synuclein in Parkinson's disease. J. Neurochem. 107, 303 316.
21. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. Riess O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106 108.
22. Lang-Rollin I., Dermentzaki G., Vekrellis K., Xilouri M., Rideout H. J. Stefanis L. (2008) A novel cell death pathway that is partially caspase dependent, but morphologically non-apoptotic, elicited by proteasomal inhibition of rat sympathetic neurons. J. Neurochem. 105, 653 665.
23. Li W., Lesuisse C., Xu Y., Troncoso J. C., Price D. L. Lee M. K. (2004) Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J. Neurosci. 24, 7400 7409. (Pubitemid 39100708)
24. Liston P., Fong W. G. Korneluk R. G. (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22, 8568 8580. (Pubitemid 38019194)
25. Maraganore D. M., de Andrade M., Elbaz A. et al. (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296, 661 670. (Pubitemid 44200637)
26. Martin F. L., Williamson S. J., Paleologou K. E., Allsop D. El-Agnaf O. M. (2004) Alpha-synuclein and the pathogenesis of Parkinson's disease. Protein Pept. Lett. 11, 229 237.
27. Martin L. J., Pan Y., Price A. C., Sterling W., Copeland N. G., Jenkins N. A., Price D. L. Lee M. K. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41 50. (Pubitemid 43089519)
28. McLaurin J., Golomb R., Jurewicz A., Antel J. P. Fraser P. E. (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicity. J. Biol. Chem. 275, 18495 18502. (Pubitemid 30414810)
29. Miloso M., Villa D., Crimi M., Galbiati S., Donzelli E., Nicolini G. Tredici G. (2004) Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J. Neurosci. Res. 75, 241 252. (Pubitemid 38049395)
30. Petrucelli L., O'Farrell C., Lockhart P. J. et al. (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36, 1007 1019. (Pubitemid 36044504)
31. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047. (Pubitemid 27443610)
32. Psarra A. M., Solakidi S., Trougakos I. P., Margaritis L. H., Spyrou G. Sekeris C. E. (2005) Glucocorticoid receptor isoforms in human hepatocarcinoma HepG2 and SaOS-2 osteosarcoma cells: presence of glucocorticoid receptor alpha in mitochondria and of glucocorticoid receptor beta in nucleoli. Int. J. Biochem. Cell Biol. 37, 2544 2558. (Pubitemid 41400324)
33. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J. Lal R. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl Acad. Sci. USA 102, 10427 10432. (Pubitemid 41061570)
34. Rukenstein A., Rydel R. E. Greene L. A. (1991) Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription- independent mechanisms. J. Neurosci. 11, 2552 2563.
35. Singleton A. B., Singleton A., Hague S. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841. (Pubitemid 37339619)
36. Smith W. W., Jiang H., Pei Z., Tanaka Y., Morita H., Sawa A., Dawson V. L., Dawson T. M. Ross C. A. (2005) Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum. Mol. Genet. 14, 3801 3811. (Pubitemid 43020082)
37. Stefanis L. (2005) Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist 11, 50 62. (Pubitemid 40223090)
38. Stefanis L., Burke R. E. Greene L. A. (1997a) Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10, 299 305. (Pubitemid 27355008)
39. Stefanis L., Troy C. M., Qi H. Greene L. A. (1997b) Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J. Neurochem. 69, 1425 1437. (Pubitemid 27406943)
40. Stefanis L., Park D. S., Friedman W. J. Greene L. A. (1999) Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J. Neurosci. 19, 6235 6247. (Pubitemid 29347424)
41. Stefanis L., Larsen K. E., Rideout H. J., Sulzer D. Greene L. A. (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 21, 9549 9560. (Pubitemid 34184043)
42. Townsend M., Shankar G. M., Mehta T., Walsh D. M. Selkoe D. J. (2006a) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572, 477 492. (Pubitemid 44236631)
43. Townsend M., Cleary J. P., Mehta T., Hofmeister J., Lesne S., O'Hare E., Walsh D. M. Selkoe D. J. (2006b) Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann. Neurol. 60, 668 676. (Pubitemid 46048484)
44. Tzeng H. F., Chen J. Y., Huang S. W., Wang Y. J. Yang C. S. (2007) Simultaneous determination of myo-inositol and scyllo-inositol by MEKC as a rapid monitoring tool for inositol levels. Electrophoresis 28, 1221 1228. (Pubitemid 46711856)
45. Vekrellis K., Rideout H. J. Stefanis L. (2004) Neurobiology of alpha-synuclein. Mol. Neurobiol. 30, 1 21.
46. Vogiatzi T., Xilouri M., Vekrellis K. Stefanis L. (2008) Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 283, 23542 23556.
47. Volles M. J., Lee S. J., Rochet J. C., Shtilerman M. D., Ding T. T., Kessler J. C. Lansbury P. T. Jr (2001) Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812 7819. (Pubitemid 32622972)
48. Zarranz J. J., Alegre J., Gomez-Esteban J. C. et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164 173. (Pubitemid 38166992)
49. Zhou W., Hurlbert M. S., Schaack J., Prasad K. N. Freed C. R. (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866, 33 43. (Pubitemid 30313005)
50. Zhu C., Qiu L., Wang X., Hallin U., Cande C., Kroemer G., Hagberg H. Blomgren K. (2003) Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J. Neurochem. 86, 306 317. (Pubitemid 36842430)